Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial.

Pinder LF, Parham GP, Basu P, Muwonge R, Lucas E, Nyambe N, Sauvaget C, Mwanahamuntu MH, Sankaranarayanan R, Prendiville W.

Lancet Oncol. 2019 Nov 13. pii: S1470-2045(19)30635-7. doi: 10.1016/S1470-2045(19)30635-7. [Epub ahead of print]

PMID:
31734069
2.

Using Low-Cost Virtual Reality Simulation to Build Surgical Capacity for Cervical Cancer Treatment.

Bing EG, Parham GP, Cuevas A, Fisher B, Skinner J, Mwanahamuntu M, Sullivan R.

J Glob Oncol. 2019 May;5:1-7. doi: 10.1200/JGO.18.00263.

3.

Challenges, Opportunities, and Priorities for Advancing Breast Cancer Control in Zambia: A Consultative Meeting on Breast Cancer Control.

Cabanes A, Kapambwe S, Citonje-Msadabwe S, Parham GP, Lishimpi K, Cruz TA, Shastri S.

J Glob Oncol. 2019 Mar;5:1-7. doi: 10.1200/JGO.18.00222.

4.

Partnering with traditional Chiefs to expand access to cervical cancer prevention services in rural Zambia.

Kapambwe S, Mwanahamuntu M, Pinder LF, Chisele S, Chirwa SC, Parham GP.

Int J Gynaecol Obstet. 2019 Mar;144(3):297-301. doi: 10.1002/ijgo.12750. Epub 2019 Jan 16.

PMID:
30580443
5.

Leverage of an Existing Cervical Cancer Prevention Service Platform to Initiate Breast Cancer Control Services in Zambia: Experiences and Early Outcomes.

Pinder LF, Henry-Tillman R, Linyama D, Kusweje V, Nzayisenga JB, Shibemba A, Sahasrabuddhe V, Lishimpi K, Mwanahamuntu M, Hicks M, Parham GP.

J Glob Oncol. 2018 Sep;4:1-8. doi: 10.1200/JGO.17.00026. Epub 2017 Sep 8.

6.

Demonstration of an algorithm to overcome health system-related barriers to timely diagnosis of breast diseases in rural Zambia.

Pinder LF, Nzayisenga JB, Shibemba A, Kusweje V, Chiboola H, Amuyunzu-Nyamongo M, Kapambwe S, Mwaba C, Lermontov P, Mumba C, Henry-Tillman R, Parham GP.

PLoS One. 2018 May 10;13(5):e0196985. doi: 10.1371/journal.pone.0196985. eCollection 2018.

7.

Clinical Performance Validation of 4 Point-of-Care Cervical Cancer Screening Tests in HIV-Infected Women in Zambia.

Chibwesha CJ, Frett B, Katundu K, Bateman AC, Shibemba A, Kapambwe S, Mwanahamuntu MH, Banda S, Hamusimbi C, Polepole P, Parham GP.

J Low Genit Tract Dis. 2016 Jul;20(3):218-23. doi: 10.1097/LGT.0000000000000206.

8.

Point-of-care test for cervical cancer in LMICs.

Mohammed SI, Ren W, Flowers L, Rajwa B, Chibwesha CJ, Parham GP, Irudayaraj JM.

Oncotarget. 2016 Apr 5;7(14):18787-97. doi: 10.18632/oncotarget.7709.

9.

Global cancer surgery: delivering safe, affordable, and timely cancer surgery.

Sullivan R, Alatise OI, Anderson BO, Audisio R, Autier P, Aggarwal A, Balch C, Brennan MF, Dare A, D'Cruz A, Eggermont AM, Fleming K, Gueye SM, Hagander L, Herrera CA, Holmer H, Ilbawi AM, Jarnheimer A, Ji JF, Kingham TP, Liberman J, Leather AJ, Meara JG, Mukhopadhyay S, Murthy SS, Omar S, Parham GP, Pramesh CS, Riviello R, Rodin D, Santini L, Shrikhande SV, Shrime M, Thomas R, Tsunoda AT, van de Velde C, Veronesi U, Vijaykumar DK, Watters D, Wang S, Wu YL, Zeiton M, Purushotham A.

Lancet Oncol. 2015 Sep;16(11):1193-224. doi: 10.1016/S1470-2045(15)00223-5. Review.

PMID:
26427363
10.

Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia.

Kapambwe S, Sahasrabuddhe VV, Blevins M, Mwanahamuntu MH, Mudenda V, Shepherd BE, Chibwesha CJ, Pfaendler KS, Hicks ML, Vermund SH, Stringer JS, Parham GP.

J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):e20-6. doi: 10.1097/QAI.0000000000000685.

11.

The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study.

Bateman AC, Katundu K, Mwanahamuntu MH, Kapambwe S, Sahasrabuddhe VV, Hicks ML, Chi BH, Stringer JS, Parham GP, Chibwesha CJ.

BMC Cancer. 2015 Jul 24;15:541. doi: 10.1186/s12885-015-1558-5.

12.

The Effect of Cryotherapy on Human Papillomavirus Clearance Among HIV-Positive Women in Lusaka, Zambia.

Katundu K, Bateman AC, Pfaendler KS, Mwanahamuntu MH, Kapambwe S, Vermund SH, Sahasrabuddhe VV, Msadabwe SC, Stringer JS, Parham GP, Chibwesha CJ.

J Low Genit Tract Dis. 2015 Oct;19(4):301-6. doi: 10.1097/LGT.0000000000000131.

13.

Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia.

Parham GP, Mwanahamuntu MH, Kapambwe S, Muwonge R, Bateman AC, Blevins M, Chibwesha CJ, Pfaendler KS, Mudenda V, Shibemba AL, Chisele S, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Chi BH, Stringer JS, Sankaranarayanan R, Sahasrabuddhe VV.

PLoS One. 2015 Apr 17;10(4):e0122169. doi: 10.1371/journal.pone.0122169. eCollection 2015.

14.

Identification of human papillomaviruses from formalin-fixed, paraffin-embedded pre-cancer and invasive cervical cancer specimens in Zambia: a cross-sectional study.

Bateman AC, Katundu K, Polepole P, Shibemba A, Mwanahamuntu M, Dittmer DP, Parham GP, Chibwesha CJ.

Virol J. 2015 Jan 16;12:2. doi: 10.1186/s12985-014-0234-8.

15.

Minimizing verification bias in cervical cancer screening of HIV-infected women.

Bateman AC, Chibwesha CJ, Parham GP.

Int J Gynaecol Obstet. 2015 Mar;128(3):269-70. doi: 10.1016/j.ijgo.2014.09.007. Epub 2014 Oct 24. No abstract available.

16.

Preference for human papillomavirus-based cervical cancer screening: results of a choice-based conjoint study in Zambia.

Chamot E, Mulambia C, Kapambwe S, Shrestha S, Parham GP, Macwan'gi M, Mwanahamuntu MH.

J Low Genit Tract Dis. 2015 Apr;19(2):119-23. doi: 10.1097/LGT.0000000000000081.

17.

Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia.

Bateman AC, Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Kapambwe S, Katundu K, Nkole T, Mulundika J, Pfaendler KS, Hicks ML, Shibemba A, Vermund SH, Stringer JS, Chibwesha CJ.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):212-5. doi: 10.1097/QAI.0000000000000270.

18.

Monitoring the performance of "screen-and-treat" cervical cancer prevention programs.

Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, Kapambwe S, Shepherd BE, Chibwesha C, Pfaendler KS, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Stringer JSA, Parham GP.

Int J Gynaecol Obstet. 2014 Jul;126(1):88-89. doi: 10.1016/j.ijgo.2014.01.006. Epub 2014 Feb 25. No abstract available.

19.

The burden of human papillomavirus infections and related diseases in sub-saharan Africa.

De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP.

Vaccine. 2013 Dec 29;31 Suppl 5:F32-46. doi: 10.1016/j.vaccine.2012.07.092. Review.

20.

Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia.

Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, Kapambwe S, Shepherd BE, Chibwesha C, Pfaendler KS, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Stringer JS, Parham GP.

PLoS One. 2013 Sep 18;8(9):e74607. doi: 10.1371/journal.pone.0074607. eCollection 2013.

21.

Exploring a road map to counter misconceptions about the cervicovaginal microbiome and disease.

Macklaim JM, Cohen CR, Donders G, Gloor GB, Hill JE, Parham GP, Ravel J, Spear G, van de Wijgert J, Reid G.

Reprod Sci. 2012 Nov;19(11):1154-62. doi: 10.1177/1933719112446075. Epub 2012 May 21. Review.

22.

'Worse than HIV' or 'not as serious as other diseases'? Conceptualization of cervical cancer among newly screened women in Zambia.

White HL, Mulambia C, Sinkala M, Mwanahamuntu MH, Parham GP, Moneyham L, Grimley DM, Chamot E.

Soc Sci Med. 2012 May;74(10):1486-93. doi: 10.1016/j.socscimed.2012.01.028. Epub 2012 Mar 7.

23.

Motivations and experiences of women who accessed "see and treat" cervical cancer prevention services in Zambia.

White HL, Mulambia C, Sinkala M, Mwanahamuntu MH, Parham GP, Kapambwe S, Moneyham L, Kempf MC, Chamot E.

J Psychosom Obstet Gynaecol. 2012 Jun;33(2):91-8. doi: 10.3109/0167482X.2012.656161. Epub 2012 Feb 28.

24.

Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential.

Sahasrabuddhe VV, Parham GP, Mwanahamuntu MH, Vermund SH.

Cancer Prev Res (Phila). 2012 Jan;5(1):11-7. doi: 10.1158/1940-6207.CAPR-11-0540. Epub 2011 Dec 12. Review.

25.

Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia.

Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, Pfaendler KS, Chibwesha C, Mkumba G, Mudenda V, Hicks ML, Vermund SH, Stringer JS, Parham GP.

PLoS Med. 2011 May;8(5):e1001032. doi: 10.1371/journal.pmed.1001032. Epub 2011 May 17.

26.

eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia.

Parham GP, Mwanahamuntu MH, Pfaendler KS, Sahasrabuddhe VV, Myung D, Mkumba G, Kapambwe S, Mwanza B, Chibwesha C, Hicks ML, Stringer JS.

J Low Genit Tract Dis. 2010 Jul;14(3):167-73. doi: 10.1097/LGT.0b013e3181cd6d5e.

27.

Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness.

Parham GP, Mwanahamuntu MH, Sahasrabuddhe VV, Westfall AO, King KE, Chibwesha C, Pfaendler KS, Mkumba G, Mudenda V, Kapambwe S, Vermund SH, Hicks ML, Stringer JS, Chi BH.

HIV Ther. 2010;4(6):703-722.

28.

HPV screening for cervical cancer in rural India.

Mwanahamuntu MH, Sahasrabuddhe VV, Parham GP.

N Engl J Med. 2009 Jul 16;361(3):305; author reply 306. No abstract available.

29.

Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia.

Mwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS, Mudenda V, Hicks ML, Vermund SH, Stringer JS, Parham GP.

AIDS. 2009 Mar 27;23(6):N1-5. doi: 10.1097/QAD.0b013e3283236e11. No abstract available.

30.

Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes.

Mwanahamuntu MH, Sahasrabuddhe VV, Stringer JS, Parham GP.

Bull World Health Organ. 2008 Aug;86(8):D-E. No abstract available.

31.

Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field.

Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JS, Parham GP.

Gynecol Oncol. 2008 Sep;110(3):402-7. doi: 10.1016/j.ygyno.2008.04.031. Epub 2008 Jun 16.

32.

Strategies for achieving healthy energy balance among African Americans in the Mississippi Delta.

Parham GP, Scarinci IC.

Prev Chronic Dis. 2007 Oct;4(4):A97. Epub 2007 Sep 15.

33.

An ethical framework for community health workers and related institutions.

Stone JR, Parham GP.

Fam Community Health. 2007 Oct-Dec;30(4):351-63.

PMID:
17873641
34.

Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia.

Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JS, Parham GP.

Br J Cancer. 2007 May 7;96(9):1480-3. Epub 2007 Apr 17.

35.

Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia.

Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH.

Gynecol Oncol. 2006 Dec;103(3):1017-22. Epub 2006 Jul 27.

36.

Predictors of outcomes for women with cervical carcinoma.

Leath CA 3rd, Straughn JM Jr, Kirby TO, Huggins A, Partridge EE, Parham GP.

Gynecol Oncol. 2005 Nov;99(2):432-6. Epub 2005 Aug 30.

PMID:
16137753
37.

Racial disparities affecting the reproductive health of African-American women.

Parham GP, Hicks ML.

Med Clin North Am. 2005 Sep;89(5):935-43, 941. Review.

PMID:
16129105
38.

Dairy report one-sided: dairy products contribute to cancer risks.

Parham GP.

J Natl Med Assoc. 2005 Apr;97(4):582-3. No abstract available.

39.

Influence of allogeneic blood transfusion on clinical outcome during radiotherapy for cancer of the uterine cervix.

Santin AD, Bellone S, Parrish RS, Coke C, Dunn D, Roman J, Theus JW, Cannon MJ, Parham GP, Pecorelli S.

Gynecol Obstet Invest. 2003;56(1):28-34. Epub 2003 Jul 14.

PMID:
12867765
40.

Comparison of cell collection and direct visualization cervical cancer screening adjuncts.

Parham GP.

Am J Obstet Gynecol. 2003 Mar;188(3 Suppl):S13-20.

PMID:
12634626
41.

A comparison of four screening methods for cervical neoplasia in a developing country.

Cronjé HS, Parham GP, Cooreman BF, de Beer A, Divall P, Bam RH.

Am J Obstet Gynecol. 2003 Feb;188(2):395-400.

PMID:
12592246
42.

Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.

Santin AD, Bellone S, Palmieri M, Bossini B, Dunn D, Roman JJ, Pecorelli S, Cannon M, Parham GP.

Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1345-55.

PMID:
12459356
43.

Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer.

Santin AD, Bellone S, Gokden M, Cannon MJ, Parham GP.

N Engl J Med. 2002 May 30;346(22):1752-3. No abstract available.

PMID:
12037163
44.

Overexpression of HER-2/neu in uterine serous papillary cancer.

Santin AD, Bellone S, Gokden M, Palmieri M, Dunn D, Agha J, Roman JJ, Hutchins L, Pecorelli S, O'Brien T, Cannon MJ, Parham GP.

Clin Cancer Res. 2002 May;8(5):1271-9.

45.

Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer.

Santin AD, Bellone S, Ravaggi A, Roman JJ, Pecorelli S, Parham GP, Cannon MJ.

Br J Cancer. 2002 Jan 7;86(1):151-7.

46.

Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer.

Santin AD, Bellone S, Ravaggi A, Roman J, Smith CV, Pecorelli S, Cannon MJ, Parham GP.

BJOG. 2001 Aug;108(8):804-8.

47.

Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.

Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman JJ, Smith CV, Pecorelli S, Radominska-Pandya A, Cannon MJ, Parham GP.

Gynecol Obstet Invest. 2001;51(4):254-61.

PMID:
11408737
49.

Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells.

Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman JJ, Jayaprabhu S, Pecorelli S, Parham GP, Cannon MJ.

Clin Cancer Res. 2001 Mar;7(3 Suppl):804s-810s.

PMID:
11300476
50.

Equal care ensures equal survival for African-American women with cervical carcinoma.

Farley JH, Hines JF, Taylor RR, Carlson JW, Parker MF, Kost ER, Rogers SJ, Harrison TA, Macri CI, Parham GP.

Cancer. 2001 Feb 15;91(4):869-73.

PMID:
11241257

Supplemental Content

Loading ...
Support Center